Summarized from a Working Group session at the 2013 Annual Meeting of the American College of Rheumatology.
ACR2013: Well adapted to electronic formats, the new Lupus Activity Scoring Tool stands up well to other disease activity indices. Also, an online toolkit of validated lupus assessment tools.
ACR2013: A new study from the Karolinska Institute in Sweden suggests that hormone therapy may reduce the risk for ACPA-positive rheumatoid arthritis.
(VIDEO) Another dictum from medical school gives way to medical research: Clicking, popping, and locking are not useful for diagnosis and prognosis of suspected meniscal tear in patients over 45. Harvard's Dr. Jeffrey Katz reveals signs that actually are informative in this age group.
Researchers found a more than tripled risk of ASDs and VSDs in children born to SLE mothers in a study reported at the recent annual meeting of the American College of Rheumatology.
(VIDEO) Data from an international lupus cohort shows the factors that correlate with permanent damage to renal, pulmonary, and other body systems. Some of them are modifiable.
(VIDEO) Researchers in Norway used data from an observational study of patients with swollen joints to see how many with early signs of rheumatoid arthritis recovered without any treatment at all, and how quickly.
(VIDEO) Noting evidence that reduced inflammation in rheumatoid arthritis may not equate with pain relief, Swedish investigators looked a residual pain treated RA patients, with troubling results.
ACR2013: A prospective study of more than 200 patients showed that biologic therapy lowered their cardiovascular disease risk by almost 12% over two years.
ACR 2013: Latest results from continuing trials of the tofacitinib show the most effective dosages for RA, good news about safety, but a warning about an age difference.